Brief: Schott Pharma Reaffirms FY 2025 Guidance

SCHOTT Pharma AG & Co KgaA

15/05/2025 06:03

May 15 (Reuters) - SCHOTT Pharma AG & Co KgaA 1SXP.DE:

REAFFIRMS FY 2025 GUIDANCE

ON US TARIFFS: DIRECT IMPACT IS EXPECTED TO BE LIMITED

Source text: ID:nEQc2dTfGa

Further company coverage: 1SXP.DE

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))